• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[克服耐药性的策略]

[Strategies for the overcoming of drug resistance].

作者信息

Saijo N

机构信息

Pharmacology Division, National Cancer Center Research Institute.

出版信息

Gan To Kagaku Ryoho. 1995 Feb;22(3):371-81.

PMID:7880108
Abstract

The purpose of the studies for drug resistance could be summarized in the following four points. 1) Mechanisms of acquired drug resistance can be translated to those of inherent resistance. 2) Molecular targets of anticancer drugs can be clarified and accurate application of methods for the overcoming of drug resistance may be possible. 3) Important hints can be obtained for the development of new anticancer agents against molecular targets. 4) Efficient methods can be provided to find new anticancer agents against drug refractory tumors. The clinical strategies for the overcoming of drug resistance are 1) the use of non cross-resistant drugs, 2) the application of the drugs for overcoming resistance, 3) high dose chemotherapy, and 4) the combined use of radiotherapy and surgery.

摘要

耐药性研究的目的可归纳为以下四点。1)获得性耐药机制可转化为固有耐药机制。2)可明确抗癌药物的分子靶点,并可能准确应用克服耐药性的方法。3)可为针对分子靶点开发新型抗癌药物提供重要线索。4)可为寻找针对难治性肿瘤的新型抗癌药物提供有效方法。克服耐药性的临床策略包括:1)使用非交叉耐药药物;2)应用克服耐药性的药物;3)大剂量化疗;4)放疗与手术联合使用。

相似文献

1
[Strategies for the overcoming of drug resistance].[克服耐药性的策略]
Gan To Kagaku Ryoho. 1995 Feb;22(3):371-81.
2
[Advance in studies on molecular mechanisms of cisplatin resistance and intervention with traditional Chinese medicines].[顺铂耐药分子机制及中药干预研究进展]
Zhongguo Zhong Yao Za Zhi. 2014 Sep;39(17):3216-20.
3
[Mechanisms of acquired resistance to DNA topoisomerase I inhibitors].[获得性对DNA拓扑异构酶I抑制剂耐药的机制]
Gan To Kagaku Ryoho. 1991 Aug;18(10):1562-7.
4
Topoisomerase I inhibitors. An overview of the camptothecin analogs.拓扑异构酶I抑制剂。喜树碱类似物概述。
Hematol Oncol Clin North Am. 1994 Apr;8(2):333-55.
5
Mechanisms to improve chemotherapy effectiveness.提高化疗效果的机制。
Cancer. 1990 Feb 1;65(3 Suppl):815-22. doi: 10.1002/1097-0142(19900201)65:3+<815::aid-cncr2820651329>3.0.co;2-f.
6
Preclinical studies of water-insoluble camptothecin congeners: cytotoxicity, development of resistance, and combination treatments.水不溶性喜树碱类似物的临床前研究:细胞毒性、耐药性的产生及联合治疗
Clin Cancer Res. 1995 Nov;1(11):1235-44.
7
Cisplatin inhibits paclitaxel-induced apoptosis in cisplatin-resistant ovarian cancer cell lines: possible explanation for failure of combination therapy.顺铂抑制顺铂耐药卵巢癌细胞系中紫杉醇诱导的细胞凋亡:联合治疗失败的可能原因
Cancer Res. 1999 May 15;59(10):2425-32.
8
Novel mutation of topoisomerase I in rendering cells resistant to camptothecin.拓扑异构酶I的新型突变使细胞对喜树碱产生抗性。
Cancer Res. 2002 Jul 1;62(13):3716-21.
9
Antineoplastic drug resistance in brain tumors.脑肿瘤中的抗肿瘤药物耐药性。
Neurol Clin. 1991 May;9(2):383-404.
10
[Drug resistance and implication for therapy].[耐药性及其对治疗的影响]
Rinsho Ketsueki. 1989 Aug;30(8):1128-32.